Collagen Solutions plc announced the proposed restructuring of its New Zealand operations. The Board of Directors having undertaken an in-depth strategic review of its overall operations and capabilities has decided to explore a re-structure of its New Zealand operations for it to focus its activities in the area of Tissue collection and processing a segment the Board believe to be valued in excess of $100 million. As well as positioning the New Zealand operations for significant growth over the medium term the proposed restructuring will enable the existing collagen production to be consolidated into Glasgow and for current disparate R&D resource to be more focused. The proposed restructuring is subject to an employee consultation process expected to be concluded before the end of April.